The data suggest edoxaban can be considered, and it may give some reassurance to physicians who are already using it off-label in ... a surgical bioprosthetic aortic or mitral valve or both.

About 30,000 Americans die each year when the aortic valve fails in their heart. But the current state-of-the-art approaches of using bioprosthetic or mechanical valves made of rubber and metal as ...